ArticleClinical and translational medicine2020

Suppression of lncRNA MALAT1 by betulinic acid inhibits hepatocellular carcinoma progression by targeting IAPs via miR-22-3p.

Feiyu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.